Trial Profile
Efficacy of ledipasvie/sofosbuvir in post-liver transplant patients with chronic hepatitis C virus infection: A retrospective cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Apr 2017 New trial record
- 06 Apr 2017 Results published in the Alimentary Pharmacology and Therapeutics